Nobazit® - new indications for use

On March 28, 2023, within the framework of the XV Annual All-Russian Congress on Infectious Diseases named after the Academician V.I. Pokrovsky, a symposium was held on the viral diseases treatment current issues, entitled “Universal Approaches to the Therapy of Respiratory Viral Infections during the COVID-19 Pandemic.”


Visit of the Kemerovo Oblast – Kuzbass Governor to the “Avexima Siberia” LLC, Pharmaceutical Plant

The Kemerovo Oblast – Kuzbass Governor, Sergey Tsivilev, visited the “Avexima Siberia” LLC, Chemical and Pharmaceutical Plant in Anzhero-Sudzhensk town.


Antiviral drug “Nobazit” from “Avexima”, the Russian pharmaceutical company, at the main musical event of the year – the National Music Award “Golden Gramophone”.

The modern antiviral drug “Nobazit” has become the official sponsor of the National Music Award “Golden Gramophone”, which took place on December 10, 2022. As a gift from the sponsor, the singer and composer Dmitry Malikov received a supply of the antiviral drug “Nobazit”.


FURACILIN AVEXIMA New Packaging Release

The “Avexima”, OJSC, Pharmaceutical Company, informs you about the release of FURACILIN AVEKSIMA effervescent tablets No. 20 (5 strips of 4 tablets each) on the market in October 2022.


Launching a large-scale national advertising campaign for the FURACILIN AVEXIMA® brand

The “Avexima”, OJSC, Pharmaceutical Company, is launching a large-scale national advertising campaign for the FURACILIN AVEKSIMA® brand: on television of the Russian Federation and on the Internet with bright creativity, starting since September 1, 2022.


The Irbit Chemical and Pharmaceutical Plant (ICPP) celebrated its anniversary – 80 years since the enterprise founding

At the gala evening dedicated to the 80th anniversary of the enterprise, employees and management of the enterprise were awarded certificates of honor from the Sverdlovsk Oblast Governor and the Administration of the town of Irbit.


The “Avexima” Company and the Pharmaceutical Company “FC Grand Capital” are considering the possibility of developing drugs on Russky Island

The “Avexima” Company, jointly with the national pharmaceutical distributor, the Pharmaceutical Company “FC Grand Capital”, are considering the possibility of implementing a project to create innovative laboratories on Russky Island with the aim of reproducing and developing modern drugs.


“Avexima” Pharmaceutical Company and the national pharmaceutical distributor, the Pharmaceutical Company “FC Grand Capital” will more than double their investments in the Greater Moscow Area

On December 9, 2021, the “Avexima”, OJSC, Pharmaceutical Company, and the Moscow Oblast Development Corporation, JSC, signed an additional agreement on expanding cooperation within the framework of an investment project for the construction of a pharmaceutical production and logistics complex in the Moscow Oblast in the Esipovo Industrial Park. The project partner is the national pharmaceutical distributor of the Pharmaceutical Company “FC Grand Capital”.